25 Jul 2016 Merck Receives Breakthrough Therapy Designation from FDA and PRIME Status from EMA for Investigational Ebola Zaire Vaccine (V920)
21 Jul 2016 Transgene to Continue Phase 1/1b Study with TG1050 in Chronic Hepatitis B Patients on the Recommendation of the Trial’s Safety Review Committee
20 Jul 2016 Hookipa Biotech Initiates First-in-Human Study of Cytomegalovirus Vaccine
19 Jul 2016 VBI Vaccines Applies its eVLP Platform in the Development of a Novel Vaccine Candidate to Prevent Zika Virus
13 Jul 2016 Pfizer Receives FDA Approval for Prevnar 13® in Adults Age 18 Through 49
12 Jul 2016 New worldwide, exclusive license agreement provides broad access to Institut Pasteur's virus vector technology – Zika vaccine development progressing with high priority
12 Jul 2016 VAXIMM initiates Phase 1 translational study in glioblastoma with oral T-cell immunotherapy, VXM01
07 Jul 2016 Valneva Announces Successful Generation of a Highly-purified Zika Vaccine Candidate Using its FDA-EMA Approved Japanese Encephalitis Platform
07 Jul 2016 Immunovaccine Announces Positive Interim Phase 1 Data for DepoVax(TM)-Based Respiratory Syncytial Virus Vaccine Candidate
01 Jul 2016 First-In-Human Study of Immbio's Novel Pneumococcal Vaccine Pnubiovax Shows Vaccine to Be Safe and Immunogenic
30 Jun 2016 GeoVax Announces Filing of Investigational New Drug Application for HIV Human Clinical Trial
29 Jun 2016 Galena Biopharma Discontinues NeuVax™ (nelipepimut-S) Phase 3, PRESENT Interim Analysis based on Independent Data Monitoring Committee Recommendation
28 Jun 2016 Vaxart Initiates Clinical Development of First Oral RSV Vaccine
28 Jun 2016 DBV Technologies Announces Completion of Recruitment in Global Phase III Study of Viaskin Peanut for the Treatment of Peanut Allergic Children
23 Jun 2016 New Four-Strain Influenza Vaccine, VaxigripTetra™, Regulatory Dossier from Sanofi Pasteur Now Approved in Europe
23 Jun 2016 VBI Vaccines Begins Enrolling Patients in a Phase I Trial of its Preventative Cytomegalovirus Vaccine Candidate
23 Jun 2016 AstraZeneca provides update on Flumist Quadrivalent Vaccine in the US for the 2016-17 influenza season
22 Jun 2016 GeoVax Discusses Zika Vaccine Development at American Society for Virology's 35th Annual Meeting
22 Jun 2016 Prima BioMed Announces First Safety, Pharmacokinetics and Immuno-Monitoring Data From Phase IIb Clinical Trial of IMP321
22 Jun 2016 AXON’s Pioneering Tau Vaccine against Alzheimer's Started Phase II
21 Jun 2016 AiVita Biomedical Receives FDA Approval for Phase II Ovarian Cancer Treatment
21 Jun 2016 Circassia Announces Top-Line Results from Cat Allergy Phase III Study
20 Jun 2016 Takeda Initiates World’s First Norovirus Vaccine Field Trial
20 Jun 2016 Inovio Pharmaceuticals and GeneOne Life Science Receive Approval for First-in-Man Zika Vaccine Clinical Trial
20 Jun 2016 Vical’s Phase 1/2 Trial Data Presented at ASM 2016 Shows Bivalent Vaccine Imparts Reduction in Genital Herpes Lesions Durable to 9 Months

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing